| Status | Awaiting development |
| Technology type | Medicine |
| Decision | Awaiting decision |
| Process | Pathways Standard |
| ID number | 6443 |
Email enquiries
- If you have any queries please email scheduling@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 26 July 2024 | For information, the company have announced that trial did not meet its primary endpoint and therefore they will no longer be pursuing a Marketing Authorisation Application in this indication at this time. Therefore, NICE has decided to suspend this appraisal from its current work programme. As this appraisal has been referred NICE will continue to monitor any development and will update interested parties as and when the situation changes. |
| 24 November 2023 | Awaiting development. Status change linked to Topic Selection Decision being set to Selected |
| 24 November 2023 | Topic selection |
For further information on our processes and methods, please see our CHTE processes and methods manual